{"gene":"C9ORF72","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":2011,"finding":"GGGGCC hexanucleotide repeat expansion in the noncoding region of C9ORF72 leads to loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, establishing both loss-of-function and RNA gain-of-function as disease mechanisms.","method":"Genetic linkage analysis, repeat expansion identification, transcript analysis, RNA foci detection in patient tissue","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent landmark papers simultaneously identified the same mechanism, replicated across multiple patient cohorts and families","pmids":["21944778","21944779"],"is_preprint":false},{"year":2013,"finding":"C9ORF72 protein is structurally related to DENN (Differentially Expressed in Normal and Neoplasia) Rab-GEF proteins by sensitive homology searches, suggesting it functions as a GDP/GTP exchange factor for Rab GTPases to regulate membrane trafficking.","method":"Computational homology searches (bioinformatics structural prediction)","journal":"Bioinformatics (Oxford, England)","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no in vitro or cellular functional validation in this paper","pmids":["23329412"],"is_preprint":false},{"year":2015,"finding":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport: RanGAP1 physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, C9orf72 ALS patient iPSC-derived neurons, and patient brain tissue. Nuclear import is impaired as a result of HRE expression and is rescued by small molecules and antisense oligonucleotides targeting HRE G-quadruplexes.","method":"Candidate-based genetic screen in Drosophila, physical interaction assay (RanGAP-HRE RNA binding), immunofluorescence in patient iPSC neurons and brain tissue, nuclear import assay, small molecule/ASO rescue experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal evidence from Drosophila genetic screen, physical interaction, patient-derived iPSC neurons, and patient tissue, with pharmacological rescue","pmids":["26308891"],"is_preprint":false},{"year":2016,"finding":"C9orf72 interacts with Rab1a and the ULK1 autophagy initiation complex, and as a Rab1a effector controls initiation of autophagy by regulating Rab1a-dependent trafficking of the ULK1 complex to the phagophore. Reduction of C9orf72 in cell lines and primary neurons attenuates autophagy and causes accumulation of p62-positive puncta.","method":"Co-immunoprecipitation, pulldown assays, autophagy flux assays in cell lines and primary neurons, knockdown experiments, patient-derived iNeurons","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP for multiple binding partners, functional KD phenotype replicated in cell lines, primary neurons, and patient-derived iNeurons","pmids":["27334615"],"is_preprint":false},{"year":2016,"finding":"C9ORF72, together with SMCR8 and WDR41, forms a stable tripartite complex and acts as a GDP/GTP exchange factor (GEF) for the small RAB GTPases Rab8a and Rab39b, regulating macroautophagy. Decreased C9orf72 expression in neuronal cultures leads to autophagy dysfunction characterized by accumulation of p62/SQSTM1 aggregates.","method":"Co-immunoprecipitation identifying C9orf72-SMCR8-WDR41 complex, GEF activity assay for Rab8a and Rab39b, autophagy assays with p62 accumulation in neuronal cultures","journal":"Small GTPases","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — GEF activity assay (enzymatic) reported but from a single lab, limited methodological detail in abstract","pmids":["27494456"],"is_preprint":false},{"year":2018,"finding":"C9orf72's long isoform complexes with and stabilizes SMCR8, which further enables interaction with WDR41, forming a tripartite complex. This complex suppresses autoimmunity and negatively regulates lysosomal exocytosis; loss of C9orf72 results in increased surface LAMP1 expression and enhanced secretion of lysosomal components in macrophages.","method":"Quantitative mass spectrometry-based proteomics in motor neurons, Smcr8 loss-of-function mutant mice, LAMP1 surface expression and lysosomal secretion assays in macrophages","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — MS-based interactome plus Smcr8 KO mouse model with defined cellular phenotypes, consistent with C9orf72 KO phenotypes","pmids":["29950492"],"is_preprint":false},{"year":2018,"finding":"C9ORF72 interacts with endosomes and is required for normal vesicle trafficking and lysosomal biogenesis in motor neurons. Repeat expansion-reduced C9orf72 expression triggers neurodegeneration via accumulation of glutamate receptors (excitotoxicity) and impaired clearance of neurotoxic dipeptide repeat proteins. Restoring C9orf72 levels or augmenting function with constitutively active RAB5 rescued patient neuron survival.","method":"Human induced motor neurons (iMNs) from patient iPSCs, endosome interaction assays, vesicle trafficking assays, lysosomal biogenesis assays, RAB5 rescue experiments","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — patient iPSC-derived iMNs with multiple orthogonal assays, pathway rescue with constitutively active RAB5, and in vivo validation in mouse models","pmids":["29400714"],"is_preprint":false},{"year":2019,"finding":"C9orf72 is a component of the ULK1-RB1CC1-ATG13-ATG101 autophagy initiation complex, interacting directly with ATG13 via the isoform-specific carboxyl-terminal DENN and dDENN domain. C9orf72 knockout neurons show reduced LC3-II puncta and reduced ULK1 levels, indicating loss of C9orf72 impairs basal autophagy. Expression of the long C9orf72 isoform (but not the short isoform) rescues autophagy and dendritic arborization phenotypes.","method":"Quantitative proteomic analysis, Co-IP (C9orf72-ATG13 interaction), c9orf72 knockout mouse neurons, LC3-II autophagy flux assay, dendritic morphology quantification, isoform rescue experiments","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — proteomic identification plus Co-IP with direct binding mapped to specific domain, KO phenotype, and isoform-specific rescue","pmids":["30669939"],"is_preprint":false},{"year":2019,"finding":"C9orf72 DENN domain specifically binds to inactive Rag GTPases (but not active Rag GTPases), thereby affecting Rag/raptor/mTOR complex function and mTORC1 activity. Loss of C9orf72 leads to accumulation of lysosomes, autophagosomes, and autolysosomes, associated with suppressed mTORC1 activity and enhanced nuclear translocation of MITF, TFE3, and TFEB.","method":"Co-immunoprecipitation (C9orf72-Rag GTPase interaction), lysosomal biogenesis assays, mTORC1 activity assays, nuclear translocation assays for MiT/TFE members, rescue with active Rag GTPases","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with specificity for inactive vs. active Rag GTPases plus multiple downstream functional assays, single lab","pmids":["32100453"],"is_preprint":false},{"year":2019,"finding":"C9orf72 and Smcr8 double-knockout mice show impaired lysosomal degradation and exocytosis due to disrupted autolysosome acidification, leading to aberrant MTOR protein accumulation and MTORC1 signaling overactivation. Inhibition of hyperactive MTORC1 partially rescued macrophage dysfunction.","method":"c9orf72 and smcr8 double-knockout (dKO) mice, lysosomal pH/acidification assays, MTORC1 signaling assays, rapamycin/pharmacological MTORC1 inhibition rescue","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO mouse model with mechanistic rescue, multiple orthogonal assays, causative link established between lysosomal degradation and MTORC1","pmids":["31847700"],"is_preprint":false},{"year":2020,"finding":"Loss of C9orf72 from myeloid cells alone is sufficient to cause age-dependent lymphoid hypertrophy and autoinflammation. C9orf72-deficient dendritic cells show early type I interferon response hyperactivation, and C9orf72-deficient myeloid cells are selectively hyperresponsive to STING activators. Degradation of STING through the autolysosomal pathway is diminished in C9orf72-deficient myeloid cells; blocking STING suppresses the hyperactive interferon responses and inflammation.","method":"Myeloid cell-specific C9orf72 knockout mice, dendritic cell isolation with IFN response profiling, STING pathway activation assays, autolysosomal degradation assays, STING inhibitor rescue in mice and patient macrophages","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with mechanistic pathway placement (C9orf72 → STING lysosomal degradation → type I IFN), validated in mice and patient-derived cells","pmids":["32814898"],"is_preprint":false},{"year":2020,"finding":"C9orf72 deficiency in mice leads to a change in microglial homeostatic signature and transition to an inflammatory state with enhanced type I IFN response. C9orf72-depleted microglia trigger age-dependent enhanced cortical synaptic pruning, leading to altered learning and memory, and paradoxically improve amyloid plaque clearance while worsening synapse loss.","method":"C9orf72 conditional knockout in microglia, microglial transcriptomic profiling, synaptic pruning quantification, behavioral testing, amyloid mouse model crossing","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — microglial-specific KO with defined cellular mechanism (enhanced synaptic pruning) and multiple phenotypic readouts","pmids":["34133945"],"is_preprint":false},{"year":2021,"finding":"C9orf72 is a mitochondrial inner-membrane-associated protein that regulates energy homeostasis via oxidative phosphorylation. C9orf72 translocation from the cytosol to the inter-membrane space is mediated by the redox-sensitive AIFM1/CHCHD4 pathway. In mitochondria, C9orf72 specifically stabilizes TIMMDC1 (a crucial factor for OXPHOS complex I assembly) by directly recruiting the prohibitin complex to inhibit m-AAA protease-dependent degradation of TIMMDC1. Mitochondrial complex I function is impaired in C9orf72-linked ALS/FTD patient-derived neurons.","method":"Mitochondrial fractionation, Co-IP (C9orf72-TIMMDC1-prohibitin complex), m-AAA protease degradation assay, OXPHOS complex I activity assay, patient iPSC-derived neuron functional assessment","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — subcellular fractionation identifying novel mitochondrial localization, Co-IP of tripartite complex, protease degradation assay, validated in patient neurons","pmids":["33545050"],"is_preprint":false},{"year":2021,"finding":"C9orf72 interacts with synapsin family proteins at synapses via its N-terminal longin domain (interacting with the conserved C domain of synapsin). C9orf72 deficiency reduces the number of excitatory synapses, decreases synapsin levels at remaining synapses, impairs excitatory neurotransmission, and depletes synaptic vesicles from excitatory synapses. C9orf72 haploinsufficiency in patient hippocampus shows marked synapsin reduction.","method":"Co-IP of endogenous C9orf72-synapsin in synapses, domain mapping by pulldown, C9orf72 knockout mouse hippocampal analysis, electrophysiological recordings, electron microscopy of synaptic vesicles, patient postmortem tissue immunohistochemistry","journal":"Acta neuropathologica","confidence":"High","confidence_rationale":"Tier 2 / Strong — endogenous Co-IP with domain mapping, KO mouse in vivo phenotype, electrophysiology, and patient tissue validation","pmids":["35876881"],"is_preprint":false},{"year":2022,"finding":"C9orf72 localizes to the nucleus and is rapidly recruited to sites of DNA damage. C9orf72 deficiency results in impaired non-homologous end joining (NHEJ) repair through attenuated DNA-PK complex assembly and DNA damage response signaling. C9orf72 deficiency exacerbates poly-GR-induced neurodegeneration and leads to PARP-1 overactivation; PARP-1 inhibition rescued neuronal death.","method":"Immunofluorescence live imaging of nuclear C9orf72 at DNA damage sites, NHEJ repair assay, DNA-PK complex assembly assay, KO mouse model with poly-GR co-expression, PARP-1 inhibitor rescue in cultured neurons","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct nuclear localization with functional consequence, NHEJ assay, in vivo mouse model, single lab","pmids":["36220889"],"is_preprint":false},{"year":2017,"finding":"C9orf72 repeat expansion causes elevated levels of DNA-RNA hybrids (R-loops) and double-strand breaks. Defective ATM-mediated DNA repair is a consequence of P62 accumulation, which impairs H2A ubiquitylation and perturbs ATM signaling. Expression of C9orf72-related RNA and dipeptide repeats in mouse CNS increases double-strand breaks and ATM defects, triggering neurodegeneration.","method":"R-loop detection (S9.6 antibody), DSB quantification (γH2AX) in rat neurons/human cells/patient spinal cord, ATM signaling assays, P62 accumulation analysis, H2A ubiquitylation assay, viral vector mouse CNS expression model","journal":"Nature neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple model systems (rat, human cells, patient tissue, mouse) with mechanistic pathway (P62→H2A ubiquitylation→ATM), single lab","pmids":["28714954"],"is_preprint":false},{"year":2015,"finding":"C9ORF72 protein is localized as puncta throughout neurons including actin-rich structures such as filopodia and growth cones, and is present in synaptosome preparations from adult mouse brain, indicating a role at synapses. Different C9orf72 isoforms show differential nuclear vs. cytoplasmic expression over development.","method":"Cellular fractionation, immunofluorescence in cultured cortical neurons and brain tissue (developmental time-course), synaptosome preparation from adult mouse brain","journal":"Acta neuropathologica communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — fractionation and immunofluorescence establishing subcellular localization, with synaptosome biochemical fractionation, multiple developmental time points","pmids":["26408000"],"is_preprint":false},{"year":2023,"finding":"Loss of C9ORF72 leads to hyperactivation of the JAK-STAT pathway and increased STING protein levels. Compromised lysosome integrity in C9ORF72-deficient cells contributes to JAK/STAT-dependent inflammatory responses. JAK inhibitor treatment rescues enhanced inflammatory phenotypes in C9ORF72-deficient cells and mice.","method":"JAK-STAT pathway activation assays in C9orf72 KO cells/mice, STING protein level measurement, lysosome integrity assays, JAK inhibitor rescue experiments in vitro and in vivo","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional KO with pathway assays and pharmacological rescue in both cell culture and mice, single lab","pmids":["37250330"],"is_preprint":false},{"year":2021,"finding":"Arginine-rich poly-dipeptides (PR) from C9orf72 tightly bind karyopherin-β2 (Kapβ2) at a 1:1 ratio, targeting the NLS binding site of Kapβ2. This impedes NIR (nuclear import receptor) function as a phase modifier of RNA-binding proteins, disabling phase transitions of RBPs.","method":"Isothermal titration calorimetry (ITC), size-exclusion chromatography, nuclear magnetic resonance (NMR) of Kapβ2 perturbed by PR poly-dipeptides, comparison with designed NLS peptide","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ITC (quantitative binding), SEC, and NMR with site-specific mapping of the interaction, multiple orthogonal biophysical methods in one study","pmids":["34489423"],"is_preprint":false},{"year":2019,"finding":"Poly(PR) dipeptide repeat protein from C9orf72 binds DNA, localizes to heterochromatin, and causes HP1α liquid-phase disruptions, decreases in HP1α expression, abnormal histone methylation, and nuclear lamina invaginations. These lead to repetitive element expression and double-stranded RNA accumulation.","method":"(PR)50-GFP mouse model (brain-wide expression), chromatin binding assays, HP1α phase separation assays, histone methylation analysis, nuclear lamina imaging, dsRNA detection","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse model with multiple mechanistic readouts including chromatin binding, phase separation, epigenetic modification, and dsRNA accumulation","pmids":["30765536"],"is_preprint":false},{"year":2020,"finding":"Poly(GR) from C9orf72 repeat expansion promotes aggregation of endogenous TDP-43 in an RNA-independent manner, causing cytoplasmic TDP-43 inclusion formation. Poly(GR) also causes mislocalization of nucleocytoplasmic transport factors and nuclear pore complex proteins, leading to aberrant TDP-43 cytoplasmic accumulation and co-aggregation with poly(GR). ASO targeting of G4C2 repeats reduced poly(GR) burden and TDP-43 pathology.","method":"Co-immunoprecipitation (poly(GR)-TDP-43), RNA-independent sequestration assay, GFP-(GR)200 mouse model with nucleocytoplasmic transport factor localization analysis, ASO treatment with biochemical and pathological readouts","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP demonstrating RNA-independent mechanism, in vivo mouse model, ASO rescue with multiple endpoints","pmids":["32878979"],"is_preprint":false},{"year":2023,"finding":"The C9orf72 HRE DNA binds to DAXX protein and promotes its liquid-liquid phase separation, which reorganizes genomic structures. HRE-dependent nuclear accumulation of DAXX drives chromatin remodeling and epigenetic changes (histone hypermethylation and hypoacetylation). DAXX suppresses basal and stress-inducible expression of C9orf72 via chromatin remodeling and epigenetic modifications of the C9orf72 major transcript promoter.","method":"DNA-protein binding assay (HRE DNA-DAXX), LLPS assay, chromatin immunoprecipitation, histone modification analysis, DAXX knockdown rescue in patient-derived motor neurons","journal":"Neuron","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA-protein binding, LLPS assay, ChIP-based epigenetic analysis, and functional rescue, single lab","pmids":["36822200"],"is_preprint":false},{"year":2024,"finding":"(GGGGCC)n repeat RNA co-localizes with nuclear speckles and alters their phase separation properties and granule dynamics. The nuclear speckle scaffold protein SRRM2 is sequestered into poly-GR cytoplasmic inclusions in C9-FTD/ALS mouse model and patient postmortem tissues. Impaired nuclear speckle integrity induces global exon skipping and intron retention in human iPSC-derived neurons, causing neuronal toxicity.","method":"Single molecule imaging, co-localization assays (repeat RNA-nuclear speckles), phase separation assays, SRRM2 immunohistochemistry in mouse model and patient tissue, iPSC-derived neuron RNA splicing analysis, neuronal toxicity assay","journal":"Neuron","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct imaging of RNA-nuclear speckle interaction with phase separation assay, mouse model, patient tissue, and iPSC validation, single lab","pmids":["39181135"],"is_preprint":false},{"year":2021,"finding":"RAN translation of C9orf72 G4C2 repeats is regulated by double-stranded RNA-dependent protein kinase (PKR): G4C2 expansion RNAs activate PKR, leading to increased levels of multiple RAN proteins. Blocking PKR reduces RAN protein levels. p-PKR is elevated in C9orf72 ALS/FTD human and mouse brains, and inhibiting PKR (via AAV-PKR-K296R or metformin) decreases RAN proteins and improves behavior and pathology in C9orf72 BAC transgenic mice.","method":"PKR activation assays with structured repeat RNAs, PKR-K296R dominant-negative blockade, PKR-KO cells, RAN protein level quantification, C9orf72 BAC transgenic mouse AAV injection and metformin treatment with behavioral/pathological endpoints","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic PKR regulation of RAN translation established in cells, validated in human tissue, and rescued in vivo with two independent approaches","pmids":["32690681"],"is_preprint":false},{"year":2021,"finding":"The RNA helicase DHX36 (G4R1) modulates C9orf72 G4C2 repeat-associated non-AUG (RAN) translation: DHX36 depletion suppresses RAN translation in a repeat length-dependent manner, while DHX36 overexpression enhances RAN translation from G4C2 reporter RNAs. DHX36 is required for integrated stress response-triggered upregulation of RAN translation.","method":"Luciferase reporter assays in cells and in vitro, DHX36 depletion and overexpression experiments, integrated stress response activation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays both in cells and in vitro with gain- and loss-of-function, single lab","pmids":["34174288"],"is_preprint":false},{"year":2021,"finding":"Neurons expressing poly(PR) from the C9orf72 repeat expansion activate a highly specific p53-dependent transcriptional program. Ablating p53 in mice completely rescues neurons from poly(PR)-induced degeneration and markedly increases survival in a C9orf72 mouse model. p53 activates downstream Puma to drive neurodegeneration.","method":"Chromatin accessibility profiling (ATAC-seq) and transcriptomics in degenerating neurons, p53 knockout in C9orf72 mouse model, axonal degeneration assay, patient iPSC motor neuron survival assay, C9orf72 fly model","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multi-omic approach identifying p53 as central node, KO rescue in vivo, validated across mouse, iPSC, and fly models","pmids":["33482083"],"is_preprint":false},{"year":2021,"finding":"Spliced circular intron (not pre-mRNA) containing G4C2 repeats serves as the translation template for dipeptide repeat proteins in C9ORF72 ALS/FTD. The spliced intron is stabilized in circular form due to defective lariat debranching. The NXF1-NXT1 pathway plays an important role in nuclear export of this circular intron and modulates toxic DPR production.","method":"Single molecule imaging of repeat RNA species, circular RNA characterization (lariat debranching assay), NXF1-NXT1 pathway perturbation, DPR production assays with reporter system","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single molecule imaging combined with mechanistic identification of circular intron as translation template and NXF1-NXT1 pathway role, single lab","pmids":["34389711"],"is_preprint":false},{"year":2020,"finding":"C9orf72 deficiency in macrophages results in impaired lysosomal degradation and exocytosis. C9orf72 loss of function alone (in rat) does not cause ALS phenotypes, but C9orf72 ablation combined with kainic acid-induced excitotoxicity produces motor deficits, motor neuron loss, Golgi complex fragmentation, and abnormal vesicle trafficking.","method":"C9orf72 gene deletion in rats, kainic acid excitotoxicity model, motor function testing, motor neuron histology, vesicle trafficking assays, RNA sequencing","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO rat model with direct excitotoxic challenge establishing synergistic mechanism, defined cellular phenotypes","pmids":["32745320"],"is_preprint":false}],"current_model":"C9ORF72 encodes a DENN-domain protein that forms a tripartite complex with SMCR8 and WDR41, functioning as a GEF for Rab GTPases (including Rab8a and Rab39b) to regulate vesicle trafficking, lysosomal homeostasis, mTORC1 signaling, and autophagy initiation (via direct interaction with ATG13 and the ULK1 complex); it also localizes to mitochondria to stabilize complex I assembly (by protecting TIMMDC1 from m-AAA protease degradation via the prohibitin complex), to the nucleus where it facilitates NHEJ DNA repair and is recruited to DNA damage sites, and to synapses where it interacts with synapsin to regulate excitatory neurotransmission; loss of C9ORF72 in myeloid cells impairs autolysosomal degradation of STING, causing JAK-STAT and type I interferon hyperactivation and autoinflammation, while the pathogenic GGGGCC repeat expansion simultaneously reduces C9ORF72 protein levels (haploinsufficiency) and generates toxic RNA foci that sequester RBPs and disrupt nucleocytoplasmic transport via RanGAP1 mislocalization, as well as dipeptide repeat proteins (particularly arginine-rich PR/GR) that disrupt nuclear import receptors, heterochromatin integrity, nuclear speckle function, and promote TDP-43 aggregation."},"narrative":{"mechanistic_narrative":"C9ORF72 is a DENN-domain protein that organizes membrane trafficking, lysosomal homeostasis, and autophagy, and its disruption by a noncoding GGGGCC hexanucleotide repeat expansion causes ALS/FTD through combined loss-of-function and RNA/protein gain-of-function mechanisms [PMID:21944778, PMID:21944779, PMID:23329412]. The long C9ORF72 isoform forms a stable tripartite complex with SMCR8 and WDR41 that acts as a guanine-nucleotide exchange factor for Rab GTPases including Rab8a and Rab39b, and engages Rab1a and the ULK1–RB1CC1–ATG13–ATG101 initiation complex—binding ATG13 directly through its isoform-specific C-terminal DENN/dDENN domain—to drive autophagy and lysosomal biogenesis [PMID:27334615, PMID:27494456, PMID:30669939]. Through its DENN domain it also binds inactive Rag GTPases to tune mTORC1 signaling and MiT/TFE-dependent lysosomal gene programs, and loss of C9ORF72/SMCR8 impairs autolysosome acidification and degradation while enhancing lysosomal exocytosis [PMID:32100453, PMID:31847700, PMID:29950492]. Beyond the lysosome, C9ORF72 localizes to the mitochondrial inner membrane where it recruits the prohibitin complex to protect TIMMDC1 from m-AAA protease degradation and sustain complex I assembly [PMID:33545050], to the nucleus where it is recruited to DNA damage sites to promote DNA-PK assembly and NHEJ repair [PMID:36220889], and to synapses where its N-terminal longin domain binds synapsin to support excitatory neurotransmission and synaptic vesicle pools [PMID:35876881]. In myeloid cells C9ORF72 loss impairs autolysosomal degradation of STING, driving type I interferon and JAK-STAT hyperactivation and autoinflammation [PMID:32814898, PMID:37250330], and alters microglial homeostasis and synaptic pruning [PMID:34133945]. The repeat expansion reduces C9ORF72 levels (haploinsufficiency) and generates toxic RNA foci that mislocalize RanGAP1 and disrupt nucleocytoplasmic transport [PMID:26308891], while repeat-associated non-AUG translation—templated by a spliced circular intron and regulated by PKR and DHX36—produces dipeptide repeat proteins; arginine-rich PR/GR species bind karyopherin-β2, disrupt HP1α-dependent heterochromatin, sequester the nuclear speckle scaffold SRRM2, and promote TDP-43 aggregation [PMID:34489423, PMID:30765536, PMID:32878979, PMID:39181135, PMID:32690681, PMID:34174288, PMID:34389711].","teleology":[{"year":2011,"claim":"Established the genetic cause of C9-ALS/FTD and framed the dual disease logic, showing the GGGGCC expansion both lowers a C9ORF72 transcript (loss-of-function) and forms nuclear RNA foci (RNA gain-of-function).","evidence":"Genetic linkage, repeat expansion identification, transcript analysis, and RNA foci detection in patient tissue","pmids":["21944778","21944779"],"confidence":"High","gaps":["Did not define the normal protein function lost","Did not establish which mechanism dominates pathogenesis"]},{"year":2013,"claim":"Provided the first hypothesis for C9ORF72 molecular function by recognizing it as a DENN-domain Rab-GEF-like protein, predicting a role in membrane trafficking.","evidence":"Sensitive computational homology searches","pmids":["23329412"],"confidence":"Low","gaps":["Computational prediction only with no functional validation in this study","No Rab substrate identified","No subcellular localization tested"]},{"year":2015,"claim":"Demonstrated an RNA gain-of-function pathway, showing repeat RNA binds and mislocalizes RanGAP1 to impair nucleocytoplasmic transport, and that this is pharmacologically reversible.","evidence":"Drosophila genetic screen, RanGAP–HRE RNA binding, patient iPSC neuron and brain immunofluorescence, nuclear import assays, small molecule/ASO rescue","pmids":["26308891"],"confidence":"High","gaps":["Relative contribution of foci vs DPRs to transport defect not resolved","Does not address protein loss-of-function arm"]},{"year":2015,"claim":"Localized endogenous C9ORF72 to neuronal puncta, actin-rich growth structures, and synaptosomes, providing early evidence for a synaptic and developmentally regulated role.","evidence":"Cellular fractionation, immunofluorescence time-course, and synaptosome preparation from mouse brain","pmids":["26408000"],"confidence":"Medium","gaps":["No molecular partner at synapses identified here","Isoform-specific localization not mechanistically explained"]},{"year":2016,"claim":"Converted the GEF prediction into function, defining the C9ORF72–SMCR8–WDR41 complex as a Rab8a/Rab39b GEF and as a Rab1a effector controlling ULK1-complex trafficking and autophagy initiation.","evidence":"Co-IP, pulldowns, in vitro GEF assays, and autophagy flux/p62 assays in cell lines, primary neurons, and patient iNeurons","pmids":["27334615","27494456"],"confidence":"High","gaps":["GEF activity characterized in single labs","Quantitative kinetics of nucleotide exchange not established"]},{"year":2018,"claim":"Placed C9ORF72 in vesicle trafficking and lysosomal biogenesis in motor neurons and linked its reduction to glutamate receptor accumulation and excitotoxic neurodegeneration rescuable by active RAB5.","evidence":"Patient iPSC-derived iMNs with endosome, trafficking, and lysosomal assays plus constitutively active RAB5 rescue and mouse validation","pmids":["29400714"],"confidence":"High","gaps":["Direct Rab5 GEF relationship not biochemically defined here","Link between trafficking defect and receptor accumulation correlative"]},{"year":2018,"claim":"Defined complex architecture and an immune-suppressive role, showing C9ORF72 stabilizes SMCR8 to assemble the tripartite complex and that the complex restrains lysosomal exocytosis and autoimmunity.","evidence":"Quantitative MS interactomics, Smcr8 mutant mice, and LAMP1 surface/secretion assays in macrophages","pmids":["29950492"],"confidence":"High","gaps":["Molecular control of exocytosis not fully defined","Connection to specific Rab effectors of exocytosis unresolved"]},{"year":2019,"claim":"Mapped a direct, isoform-specific autophagy mechanism, placing C9ORF72 as an ATG13-binding component of the ULK1 initiation complex via its C-terminal DENN/dDENN domain.","evidence":"Quantitative proteomics, Co-IP with domain mapping, c9orf72 KO mouse neurons, LC3-II flux, and isoform-specific rescue of autophagy and dendritic phenotypes","pmids":["30669939"],"confidence":"High","gaps":["Short isoform function remains undefined","How ATG13 binding integrates with Rab-GEF activity unclear"]},{"year":2019,"claim":"Connected C9ORF72 to nutrient signaling by showing its DENN domain selectively binds inactive Rag GTPases to modulate mTORC1 and MiT/TFE lysosomal transcription.","evidence":"Co-IP with active/inactive Rag specificity, mTORC1 and MiT/TFE nuclear translocation assays, and active-Rag rescue","pmids":["32100453"],"confidence":"Medium","gaps":["Single-lab Co-IP without structural validation","Whether C9ORF72 acts as a GEF/GDF for Rags not established"]},{"year":2017,"claim":"Linked the expansion to genome instability, showing R-loop and double-strand break accumulation downstream of p62-mediated impairment of H2A ubiquitylation and ATM signaling.","evidence":"R-loop (S9.6) and γH2AX detection across rat neurons, human cells, and patient spinal cord, ATM and H2A ubiquitylation assays, and viral CNS expression model","pmids":["28714954"],"confidence":"Medium","gaps":["Single-lab mechanism","Separation of RNA vs DPR contribution to DSBs incomplete"]},{"year":2019,"claim":"Defined a chromatin gain-of-function for arginine-rich DPRs, showing poly(PR) binds heterochromatin and disrupts HP1α phase behavior, histone methylation, and nuclear lamina, derepressing repetitive elements.","evidence":"(PR)50-GFP mouse model with chromatin binding, phase separation, epigenetic, and dsRNA readouts","pmids":["30765536"],"confidence":"High","gaps":["Disease relevance of supraphysiologic PR expression","Link to downstream neuronal death not fully traced"]},{"year":2019,"claim":"Established a causal lysosome-to-mTORC1 axis in immune cells, showing C9orf72/Smcr8 loss disrupts autolysosome acidification and overactivates MTORC1, rescuable by mTORC1 inhibition.","evidence":"c9orf72/smcr8 double-KO mice with lysosomal pH, MTORC1 signaling assays, and rapamycin rescue","pmids":["31847700"],"confidence":"High","gaps":["Apparent opposing mTORC1 effects across studies not reconciled","Cell-type specificity of mTORC1 regulation unresolved"]},{"year":2020,"claim":"Identified a myeloid autoinflammation mechanism, showing C9ORF72 loss impairs autolysosomal STING degradation to drive type I interferon hyperactivation and inflammation reversible by STING blockade.","evidence":"Myeloid-specific C9orf72 KO mice, IFN profiling, STING activation and autolysosomal degradation assays, and STING-inhibitor rescue in mice and patient macrophages","pmids":["32814898"],"confidence":"High","gaps":["Mechanism of STING delivery to autolysosomes not detailed","Relevance to neuronal pathology indirect"]},{"year":2020,"claim":"Extended the immune phenotype to brain, showing C9orf72-deficient microglia shift to an inflammatory state with enhanced synaptic pruning that impairs cognition while paradoxically clearing amyloid.","evidence":"Microglia-specific KO with transcriptomics, synaptic pruning quantification, behavior, and amyloid model crossing","pmids":["34133945"],"confidence":"High","gaps":["Molecular driver of enhanced pruning not pinpointed","Link to type I IFN signature causal chain incomplete"]},{"year":2020,"claim":"Showed C9ORF72 loss-of-function is insufficient alone for ALS phenotypes in rat but synergizes with excitotoxicity, supporting a multi-hit pathogenic model.","evidence":"C9orf72 KO rat combined with kainic acid excitotoxicity, motor and histological assays, and RNA-seq","pmids":["32745320"],"confidence":"Medium","gaps":["Species/strain dependence of phenotype","Molecular basis of excitotoxic synergy undefined"]},{"year":2020,"claim":"Defined an RNA-independent DPR toxicity route, showing poly(GR) directly drives TDP-43 aggregation and nuclear transport disruption, with ASO rescue tying it back to the repeat.","evidence":"poly(GR)-TDP-43 Co-IP, RNA-independent sequestration assays, GR mouse model, and ASO treatment","pmids":["32878979"],"confidence":"High","gaps":["Whether GR initiates or amplifies TDP-43 pathology unresolved","Quantitative contribution relative to RNA foci unclear"]},{"year":2021,"claim":"Revealed a mitochondrial function for C9ORF72, showing inner-membrane localization where it recruits prohibitin to protect TIMMDC1 from m-AAA protease degradation and sustain complex I.","evidence":"Mitochondrial fractionation, Co-IP of C9orf72–TIMMDC1–prohibitin, protease degradation and complex I activity assays, and patient neuron assessment","pmids":["33545050"],"confidence":"High","gaps":["Relationship of mitochondrial pool to the SMCR8/WDR41 complex unknown","Trigger for cytosol-to-mitochondria translocation in disease unresolved"]},{"year":2021,"claim":"Provided biophysical detail for PR-mediated transport disruption, showing poly(PR) binds karyopherin-β2 at its NLS site 1:1 to impair nuclear import receptor phase-modifier function.","evidence":"ITC, size-exclusion chromatography, and NMR mapping of Kapβ2–PR interaction","pmids":["34489423"],"confidence":"High","gaps":["In vivo consequence of this specific interaction not quantified here","Selectivity across import receptors not fully mapped"]},{"year":2021,"claim":"Identified the regulatory machinery of RAN translation, showing PKR activation by structured repeat RNA and DHX36 helicase activity control DPR production, with PKR inhibition therapeutic in mice.","evidence":"PKR activation/dominant-negative and KO assays, DHX36 gain/loss reporter assays, and AAV-PKR-K296R/metformin rescue in BAC transgenic mice","pmids":["32690681","34174288"],"confidence":"High","gaps":["DHX36 findings from single-lab reporter assays","Integration of PKR and DHX36 in same pathway not fully tested"]},{"year":2021,"claim":"Pinpointed the DPR translation template and its export route, showing a spliced circular intron stabilized by defective lariat debranching is exported by NXF1-NXT1 to template DPR synthesis.","evidence":"Single molecule imaging, circular RNA/lariat debranching characterization, and NXF1-NXT1 perturbation with DPR reporters","pmids":["34389711"],"confidence":"Medium","gaps":["Single-lab characterization","Relative DPR contribution from circular intron vs pre-mRNA unquantified"]},{"year":2021,"claim":"Identified p53 as a central effector node, showing poly(PR) activates a p53–Puma program whose ablation rescues neurodegeneration across multiple models.","evidence":"ATAC-seq/transcriptomics, p53 KO rescue in C9orf72 mice, axonal degeneration, iPSC motor neuron survival, and fly model","pmids":["33482083"],"confidence":"High","gaps":["Upstream signal linking PR to p53 activation undefined","Whether p53 axis operates downstream of loss-of-function unclear"]},{"year":2021,"claim":"Established a direct synaptic mechanism, mapping C9ORF72's N-terminal longin domain to synapsin and showing its loss reduces excitatory synapses, neurotransmission, and synaptic vesicle pools.","evidence":"Endogenous Co-IP with domain mapping, KO mouse hippocampal electrophysiology and EM, and patient tissue immunohistochemistry","pmids":["35876881"],"confidence":"High","gaps":["Functional consequence of synapsin binding on vesicle cycling not fully resolved","Relation to trafficking/autophagy roles unclear"]},{"year":2022,"claim":"Defined a nuclear DNA-repair function, showing C9ORF72 is recruited to damage sites and promotes DNA-PK assembly and NHEJ, with its loss exacerbating poly-GR toxicity via PARP-1 overactivation.","evidence":"Live imaging of nuclear recruitment, NHEJ and DNA-PK assembly assays, KO mouse with poly-GR co-expression, and PARP-1 inhibitor rescue","pmids":["36220889"],"confidence":"Medium","gaps":["Single-lab mechanism","How a trafficking protein engages NHEJ machinery structurally undefined"]},{"year":2023,"claim":"Extended inflammatory signaling, showing C9ORF72 loss elevates STING and hyperactivates JAK-STAT through compromised lysosome integrity, rescuable by JAK inhibition.","evidence":"JAK-STAT and STING assays in KO cells/mice, lysosome integrity assays, and JAK-inhibitor rescue in vitro and in vivo","pmids":["37250330"],"confidence":"Medium","gaps":["Single-lab study","Overlap with prior STING/IFN mechanism not fully integrated"]},{"year":2023,"claim":"Linked the repeat to its own transcriptional silencing, showing HRE DNA binds DAXX and promotes its phase separation, driving chromatin remodeling that suppresses C9orf72 expression.","evidence":"HRE DNA–DAXX binding, LLPS assays, ChIP/histone modification analysis, and DAXX knockdown rescue in patient motor neurons","pmids":["36822200"],"confidence":"Medium","gaps":["Single-lab study","Contribution of DAXX-driven silencing to overall haploinsufficiency unquantified"]},{"year":2024,"claim":"Identified nuclear speckle dysfunction as a toxicity mechanism, showing repeat RNA alters speckle phase properties and poly-GR sequesters SRRM2, causing splicing defects and neurotoxicity.","evidence":"Single molecule imaging, phase separation assays, SRRM2 immunohistochemistry in mouse and patient tissue, and iPSC neuron splicing/toxicity analysis","pmids":["39181135"],"confidence":"Medium","gaps":["Single-lab study","Causal ranking among speckle, transport, and TDP-43 mechanisms unresolved"]},{"year":null,"claim":"It remains unresolved how the distinct subcellular activities of C9ORF72 (lysosomal GEF, mitochondrial complex I support, nuclear NHEJ, synaptic synapsin binding) are coordinated, and how loss-of-function and the multiple gain-of-function arms are quantitatively weighted in driving neurodegeneration.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of the C9ORF72-SMCR8-WDR41 complex with Rab substrates reported in the corpus","Integration of immune, neuronal, and metabolic phenotypes into one pathogenic sequence lacking","Relative therapeutic value of targeting loss vs RNA vs DPR mechanisms unestablished"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,8]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,7,12]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[5,6,8,9]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[6]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[12]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[14,16]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[16]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[3,4,7]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[4,6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,17]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[14,15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,2]}],"complexes":["C9ORF72-SMCR8-WDR41 complex","ULK1-RB1CC1-ATG13-ATG101 autophagy initiation complex"],"partners":["SMCR8","WDR41","ATG13","RAB1A","RAB8A","TIMMDC1","SYNAPSIN","RANGAP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96LT7","full_name":"Guanine nucleotide exchange factor C9orf72","aliases":[],"length_aa":481,"mass_kda":54.3,"function":"Acts as a guanine-nucleotide releasing factor (GEF) for Rab GTPases by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:27103069, PubMed:27193190, PubMed:27617292, PubMed:28195531, PubMed:37821429). Acts as a GEF for RAB39A which enables HOPS-mediated autophagosome-lysosome membrane tethering and fusion in mammalian autophagy (PubMed:37821429). Component of the C9orf72-SMCR8 complex where both subunits display GEF activity and that regulates autophagy (PubMed:27103069, PubMed:27193190, PubMed:27617292, PubMed:28195531). As part of the C9orf72-SMCR8-WDR41 (CSW) complex, functions as GEF for RAB8A and RAB39B, thereby promoting autophagosome maturation (PubMed:27103069). As part of the C9orf72-SMCR8 complex, also functions as GTPase activating protein (GAP) for RAB8A and RAB11A in vitro (PubMed:32303654). The C9orf72-SMCR8 complex also acts as a regulator of autophagy initiation by interacting with the ULK1/ATG1 kinase complex and modulating its protein kinase activity (PubMed:27617292). Promotes initiation of autophagy by regulating the RAB1A-dependent trafficking of the ULK1/ATG1 kinase complex to the phagophore which leads to autophagosome formation (PubMed:27334615). Acts as a regulator of mTORC1 signaling by promoting phosphorylation of mTORC1 substrates (PubMed:27559131). Plays a role in endosomal trafficking (PubMed:24549040). May be involved in regulating the maturation of phagosomes to lysosomes (By similarity). Promotes the lysosomal localization and lysosome-mediated degradation of CARM1 which leads to inhibition of starvation-induced lipid metabolism (By similarity). Regulates actin dynamics in motor neurons by inhibiting the GTP-binding activity of ARF6, leading to ARF6 inactivation (PubMed:27723745). This reduces the activity of the LIMK1 and LIMK2 kinases which are responsible for phosphorylation and inactivation of cofilin, leading to CFL1/cofilin activation (PubMed:27723745). Positively regulates axon extension and axon growth cone size in spinal motor neurons (PubMed:27723745). Required for SMCR8 protein expression and localization at pre- and post-synaptic compartments in the forebrain, also regulates protein abundance of RAB3A and GRIA1/GLUR1 in post-synaptic compartments in the forebrain and hippocampus (By similarity). Plays a role within the hematopoietic system in restricting inflammation and the development of autoimmunity (By similarity) Regulates stress granule assembly in response to cellular stress Does not play a role in regulation of stress granule assembly in response to cellular stress","subcellular_location":"Nucleus membrane; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96LT7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/C9ORF72"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/C9ORF72","total_profiled":1310},"omim":[{"mim_id":"618730","title":"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS","url":"https://www.omim.org/entry/618730"},{"mim_id":"617653","title":"EQUATORIN; EQTN","url":"https://www.omim.org/entry/617653"},{"mim_id":"617652","title":"MOB KINASE ACTIVATOR 3B; MOB3B","url":"https://www.omim.org/entry/617652"},{"mim_id":"617651","title":"EQTN, MOB3B, IFNK, AND C9ORF72 ENHANCER RNA I, NONCODING","url":"https://www.omim.org/entry/617651"},{"mim_id":"617502","title":"WD REPEAT-CONTAINING PROTEIN 41; WDR41","url":"https://www.omim.org/entry/617502"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Midbody ring","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/C9ORF72"},"hgnc":{"alias_symbol":["MGC23980","DENNL72","DENND9"],"prev_symbol":[]},"alphafold":{"accession":"Q96LT7","domains":[{"cath_id":"3.30.450","chopping":"14-194","consensus_level":"high","plddt":83.7625,"start":14,"end":194},{"cath_id":"3.40.50","chopping":"202-323","consensus_level":"medium","plddt":89.0112,"start":202,"end":323}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96LT7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96LT7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96LT7-F1-predicted_aligned_error_v6.png","plddt_mean":83.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=C9ORF72","jax_strain_url":"https://www.jax.org/strain/search?query=C9ORF72"},"sequence":{"accession":"Q96LT7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96LT7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96LT7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96LT7"}},"corpus_meta":[{"pmid":"21944778","id":"PMC_21944778","title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.","date":"2011","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/21944778","citation_count":3977,"is_preprint":false},{"pmid":"21944779","id":"PMC_21944779","title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.","date":"2011","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/21944779","citation_count":3542,"is_preprint":false},{"pmid":"26308891","id":"PMC_26308891","title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26308891","citation_count":812,"is_preprint":false},{"pmid":"30120348","id":"PMC_30120348","title":"C9orf72-mediated ALS and FTD: multiple pathways to disease.","date":"2018","source":"Nature reviews. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30120348","citation_count":536,"is_preprint":false},{"pmid":"29400714","id":"PMC_29400714","title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.","date":"2018","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29400714","citation_count":465,"is_preprint":false},{"pmid":"27334615","id":"PMC_27334615","title":"The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27334615","citation_count":327,"is_preprint":false},{"pmid":"27112499","id":"PMC_27112499","title":"C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/27112499","citation_count":306,"is_preprint":false},{"pmid":"24096617","id":"PMC_24096617","title":"Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations.","date":"2013","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/24096617","citation_count":287,"is_preprint":false},{"pmid":"23329412","id":"PMC_23329412","title":"The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs.","date":"2013","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23329412","citation_count":269,"is_preprint":false},{"pmid":"32814898","id":"PMC_32814898","title":"C9orf72 in myeloid cells suppresses STING-induced inflammation.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32814898","citation_count":237,"is_preprint":false},{"pmid":"28243191","id":"PMC_28243191","title":"The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28243191","citation_count":222,"is_preprint":false},{"pmid":"32483373","id":"PMC_32483373","title":"C9orf72 suppresses systemic and neural inflammation induced by gut bacteria.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32483373","citation_count":217,"is_preprint":false},{"pmid":"25638642","id":"PMC_25638642","title":"C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.","date":"2015","source":"The Lancet. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25638642","citation_count":191,"is_preprint":false},{"pmid":"30765536","id":"PMC_30765536","title":"Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity.","date":"2019","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30765536","citation_count":173,"is_preprint":false},{"pmid":"32878979","id":"PMC_32878979","title":"C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32878979","citation_count":162,"is_preprint":false},{"pmid":"34949835","id":"PMC_34949835","title":"Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide.","date":"2021","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34949835","citation_count":150,"is_preprint":false},{"pmid":"28714954","id":"PMC_28714954","title":"C9orf72 expansion disrupts ATM-mediated chromosomal break repair.","date":"2017","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28714954","citation_count":148,"is_preprint":false},{"pmid":"24356984","id":"PMC_24356984","title":"The neuropathology associated with repeat expansions in the C9ORF72 gene.","date":"2013","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/24356984","citation_count":148,"is_preprint":false},{"pmid":"27151080","id":"PMC_27151080","title":"Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts.","date":"2016","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/27151080","citation_count":146,"is_preprint":false},{"pmid":"33482083","id":"PMC_33482083","title":"p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR).","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33482083","citation_count":139,"is_preprint":false},{"pmid":"28737506","id":"PMC_28737506","title":"Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/28737506","citation_count":136,"is_preprint":false},{"pmid":"27059391","id":"PMC_27059391","title":"There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.","date":"2016","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/27059391","citation_count":131,"is_preprint":false},{"pmid":"28522837","id":"PMC_28522837","title":"Age-related penetrance of the C9orf72 repeat expansion.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28522837","citation_count":123,"is_preprint":false},{"pmid":"34025358","id":"PMC_34025358","title":"C9ORF72: What It Is, What It Does, and Why It Matters.","date":"2021","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34025358","citation_count":122,"is_preprint":false},{"pmid":"33545050","id":"PMC_33545050","title":"C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33545050","citation_count":121,"is_preprint":false},{"pmid":"34247168","id":"PMC_34247168","title":"Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.","date":"2021","source":"Neuroepidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/34247168","citation_count":121,"is_preprint":false},{"pmid":"34133945","id":"PMC_34133945","title":"C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation.","date":"2021","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/34133945","citation_count":114,"is_preprint":false},{"pmid":"32690681","id":"PMC_32690681","title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32690681","citation_count":113,"is_preprint":false},{"pmid":"33632058","id":"PMC_33632058","title":"C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/33632058","citation_count":101,"is_preprint":false},{"pmid":"28130314","id":"PMC_28130314","title":"Disease Mechanisms of C9ORF72 Repeat Expansions.","date":"2018","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28130314","citation_count":90,"is_preprint":false},{"pmid":"28611593","id":"PMC_28611593","title":"Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28611593","citation_count":78,"is_preprint":false},{"pmid":"28238272","id":"PMC_28238272","title":"Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians?","date":"2017","source":"The Journal of neuropsychiatry and clinical neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/28238272","citation_count":74,"is_preprint":false},{"pmid":"34389711","id":"PMC_34389711","title":"Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS/FTD.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34389711","citation_count":65,"is_preprint":false},{"pmid":"32855285","id":"PMC_32855285","title":"Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder.","date":"2020","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/32855285","citation_count":65,"is_preprint":false},{"pmid":"33259633","id":"PMC_33259633","title":"Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33259633","citation_count":63,"is_preprint":false},{"pmid":"29453960","id":"PMC_29453960","title":"Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.","date":"2018","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/29453960","citation_count":62,"is_preprint":false},{"pmid":"26555807","id":"PMC_26555807","title":"An amyloid-like cascade hypothesis for C9orf72 ALS/FTD.","date":"2015","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26555807","citation_count":62,"is_preprint":false},{"pmid":"37714849","id":"PMC_37714849","title":"Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37714849","citation_count":60,"is_preprint":false},{"pmid":"30368547","id":"PMC_30368547","title":"C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies.","date":"2018","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/30368547","citation_count":59,"is_preprint":false},{"pmid":"29950492","id":"PMC_29950492","title":"The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29950492","citation_count":56,"is_preprint":false},{"pmid":"27494456","id":"PMC_27494456","title":"C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27494456","citation_count":55,"is_preprint":false},{"pmid":"30945056","id":"PMC_30945056","title":"ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.","date":"2019","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/30945056","citation_count":55,"is_preprint":false},{"pmid":"30669939","id":"PMC_30669939","title":"The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30669939","citation_count":55,"is_preprint":false},{"pmid":"29326544","id":"PMC_29326544","title":"Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS.","date":"2017","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29326544","citation_count":52,"is_preprint":false},{"pmid":"30774737","id":"PMC_30774737","title":"Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion.","date":"2019","source":"Behavioural neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30774737","citation_count":50,"is_preprint":false},{"pmid":"28266105","id":"PMC_28266105","title":"C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease.","date":"2017","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/28266105","citation_count":49,"is_preprint":false},{"pmid":"24515836","id":"PMC_24515836","title":"The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues.","date":"2014","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/24515836","citation_count":48,"is_preprint":false},{"pmid":"28364657","id":"PMC_28364657","title":"Genetic models of C9orf72: what is toxic?","date":"2017","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/28364657","citation_count":45,"is_preprint":false},{"pmid":"31847700","id":"PMC_31847700","title":"C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31847700","citation_count":45,"is_preprint":false},{"pmid":"28824365","id":"PMC_28824365","title":"The Enigmatic Role of C9ORF72 in Autophagy.","date":"2017","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28824365","citation_count":44,"is_preprint":false},{"pmid":"27461252","id":"PMC_27461252","title":"Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition.","date":"2016","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/27461252","citation_count":44,"is_preprint":false},{"pmid":"29729808","id":"PMC_29729808","title":"Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models.","date":"2018","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/29729808","citation_count":43,"is_preprint":false},{"pmid":"30745340","id":"PMC_30745340","title":"Nuclear RNA foci from C9ORF72 expansion mutation form paraspeckle-like bodies.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/30745340","citation_count":43,"is_preprint":false},{"pmid":"36967384","id":"PMC_36967384","title":"Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations.","date":"2023","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/36967384","citation_count":43,"is_preprint":false},{"pmid":"27134035","id":"PMC_27134035","title":"C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.","date":"2016","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/27134035","citation_count":41,"is_preprint":false},{"pmid":"25731823","id":"PMC_25731823","title":"The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis.","date":"2015","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25731823","citation_count":41,"is_preprint":false},{"pmid":"33055097","id":"PMC_33055097","title":"Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains.","date":"2020","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/33055097","citation_count":41,"is_preprint":false},{"pmid":"24836899","id":"PMC_24836899","title":"Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.","date":"2014","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/24836899","citation_count":40,"is_preprint":false},{"pmid":"32100453","id":"PMC_32100453","title":"C9orf72 associates with inactive Rag GTPases and regulates mTORC1-mediated autophagosomal and lysosomal biogenesis.","date":"2020","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/32100453","citation_count":40,"is_preprint":false},{"pmid":"30037833","id":"PMC_30037833","title":"C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in Drosophila Glutamatergic Neurons.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30037833","citation_count":39,"is_preprint":false},{"pmid":"34174288","id":"PMC_34174288","title":"The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34174288","citation_count":38,"is_preprint":false},{"pmid":"32829028","id":"PMC_32829028","title":"RNA-mediated toxicity in C9orf72 ALS and FTD.","date":"2020","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32829028","citation_count":37,"is_preprint":false},{"pmid":"28130313","id":"PMC_28130313","title":"The Genetics of C9orf72 Expansions.","date":"2018","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28130313","citation_count":36,"is_preprint":false},{"pmid":"35620137","id":"PMC_35620137","title":"Expanding Clinical Spectrum of C9ORF72-Related Disorders and Promising Therapeutic Strategies: A Review.","date":"2022","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35620137","citation_count":36,"is_preprint":false},{"pmid":"38431841","id":"PMC_38431841","title":"Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38431841","citation_count":35,"is_preprint":false},{"pmid":"24366528","id":"PMC_24366528","title":"Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.","date":"2013","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/24366528","citation_count":34,"is_preprint":false},{"pmid":"29845007","id":"PMC_29845007","title":"Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers.","date":"2018","source":"NeuroImage. Clinical","url":"https://pubmed.ncbi.nlm.nih.gov/29845007","citation_count":33,"is_preprint":false},{"pmid":"28744202","id":"PMC_28744202","title":"RNA Misprocessing in C9orf72-Linked Neurodegeneration.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28744202","citation_count":32,"is_preprint":false},{"pmid":"27349438","id":"PMC_27349438","title":"Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27349438","citation_count":31,"is_preprint":false},{"pmid":"26408000","id":"PMC_26408000","title":"C9ORF72 expression and cellular localization over mouse development.","date":"2015","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/26408000","citation_count":31,"is_preprint":false},{"pmid":"36220889","id":"PMC_36220889","title":"C9orf72 functions in the nucleus to regulate DNA damage repair.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/36220889","citation_count":30,"is_preprint":false},{"pmid":"34489423","id":"PMC_34489423","title":"C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34489423","citation_count":30,"is_preprint":false},{"pmid":"28615433","id":"PMC_28615433","title":"Disease progression in C9orf72 mutation carriers.","date":"2017","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28615433","citation_count":30,"is_preprint":false},{"pmid":"35876881","id":"PMC_35876881","title":"An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.","date":"2022","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/35876881","citation_count":29,"is_preprint":false},{"pmid":"39986312","id":"PMC_39986312","title":"Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics.","date":"2025","source":"The Lancet. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/39986312","citation_count":28,"is_preprint":false},{"pmid":"39181135","id":"PMC_39181135","title":"Disruption of nuclear speckle integrity dysregulates RNA splicing in C9ORF72-FTD/ALS.","date":"2024","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/39181135","citation_count":27,"is_preprint":false},{"pmid":"34049163","id":"PMC_34049163","title":"FDG-PET in presymptomatic C9orf72 mutation carriers.","date":"2021","source":"NeuroImage. Clinical","url":"https://pubmed.ncbi.nlm.nih.gov/34049163","citation_count":27,"is_preprint":false},{"pmid":"28005462","id":"PMC_28005462","title":"Recognition of c9orf72 Mutant RNA by Single-Stranded Silencing RNAs.","date":"2016","source":"Nucleic acid therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28005462","citation_count":27,"is_preprint":false},{"pmid":"25590632","id":"PMC_25590632","title":"Emerging role of RNA•DNA hybrids in C9orf72-linked neurodegeneration.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25590632","citation_count":26,"is_preprint":false},{"pmid":"27774051","id":"PMC_27774051","title":"C9orf72's Interaction with Rab GTPases-Modulation of Membrane Traffic and Autophagy.","date":"2016","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27774051","citation_count":26,"is_preprint":false},{"pmid":"23153366","id":"PMC_23153366","title":"Neuroimaging features of C9ORF72 expansion.","date":"2012","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23153366","citation_count":25,"is_preprint":false},{"pmid":"23934648","id":"PMC_23934648","title":"C9ORF72 mutations in neurodegenerative diseases.","date":"2013","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23934648","citation_count":25,"is_preprint":false},{"pmid":"36511398","id":"PMC_36511398","title":"Longitudinal Effects of Asymptomatic C9orf72 Carriership on Brain Morphology.","date":"2022","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36511398","citation_count":25,"is_preprint":false},{"pmid":"37847372","id":"PMC_37847372","title":"Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.","date":"2023","source":"Neurology and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37847372","citation_count":24,"is_preprint":false},{"pmid":"31773397","id":"PMC_31773397","title":"Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms.","date":"2019","source":"Current neurology and neuroscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31773397","citation_count":24,"is_preprint":false},{"pmid":"36800288","id":"PMC_36800288","title":"Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36800288","citation_count":24,"is_preprint":false},{"pmid":"33967699","id":"PMC_33967699","title":"Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD.","date":"2021","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33967699","citation_count":24,"is_preprint":false},{"pmid":"33129345","id":"PMC_33129345","title":"RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.","date":"2020","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/33129345","citation_count":23,"is_preprint":false},{"pmid":"25261695","id":"PMC_25261695","title":"Biomarker development for C9orf72 repeat expansion in ALS.","date":"2014","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25261695","citation_count":23,"is_preprint":false},{"pmid":"35895140","id":"PMC_35895140","title":"HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.","date":"2022","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/35895140","citation_count":22,"is_preprint":false},{"pmid":"33906932","id":"PMC_33906932","title":"Early life involvement in C9orf72 repeat expansion carriers.","date":"2021","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33906932","citation_count":21,"is_preprint":false},{"pmid":"24753999","id":"PMC_24753999","title":"C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.","date":"2014","source":"American journal of neurodegenerative disease","url":"https://pubmed.ncbi.nlm.nih.gov/24753999","citation_count":20,"is_preprint":false},{"pmid":"31144027","id":"PMC_31144027","title":"Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.","date":"2019","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/31144027","citation_count":20,"is_preprint":false},{"pmid":"31568865","id":"PMC_31568865","title":"C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis.","date":"2019","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/31568865","citation_count":19,"is_preprint":false},{"pmid":"23439112","id":"PMC_23439112","title":"RANTing about C9orf72.","date":"2013","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/23439112","citation_count":19,"is_preprint":false},{"pmid":"32745320","id":"PMC_32745320","title":"Ablation of C9orf72 together with excitotoxicity induces ALS in rats.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/32745320","citation_count":19,"is_preprint":false},{"pmid":"37250330","id":"PMC_37250330","title":"C9ORF72 suppresses JAK-STAT mediated inflammation.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37250330","citation_count":18,"is_preprint":false},{"pmid":"36822200","id":"PMC_36822200","title":"DNA-initiated epigenetic cascades driven by C9orf72 hexanucleotide repeat.","date":"2023","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/36822200","citation_count":18,"is_preprint":false},{"pmid":"24090760","id":"PMC_24090760","title":"The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations.","date":"2013","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24090760","citation_count":18,"is_preprint":false},{"pmid":"32678027","id":"PMC_32678027","title":"C9orf72-associated SMCR8 protein binds in the ubiquitin pathway and with proteins linked with neurological disease.","date":"2020","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/32678027","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48208,"output_tokens":7960,"usd":0.132012,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17515,"output_tokens":7896,"usd":0.142487,"stage2_stop_reason":"end_turn"},"total_usd":0.274499,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"GGGGCC hexanucleotide repeat expansion in the noncoding region of C9ORF72 leads to loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, establishing both loss-of-function and RNA gain-of-function as disease mechanisms.\",\n      \"method\": \"Genetic linkage analysis, repeat expansion identification, transcript analysis, RNA foci detection in patient tissue\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent landmark papers simultaneously identified the same mechanism, replicated across multiple patient cohorts and families\",\n      \"pmids\": [\"21944778\", \"21944779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"C9ORF72 protein is structurally related to DENN (Differentially Expressed in Normal and Neoplasia) Rab-GEF proteins by sensitive homology searches, suggesting it functions as a GDP/GTP exchange factor for Rab GTPases to regulate membrane trafficking.\",\n      \"method\": \"Computational homology searches (bioinformatics structural prediction)\",\n      \"journal\": \"Bioinformatics (Oxford, England)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no in vitro or cellular functional validation in this paper\",\n      \"pmids\": [\"23329412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport: RanGAP1 physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, C9orf72 ALS patient iPSC-derived neurons, and patient brain tissue. Nuclear import is impaired as a result of HRE expression and is rescued by small molecules and antisense oligonucleotides targeting HRE G-quadruplexes.\",\n      \"method\": \"Candidate-based genetic screen in Drosophila, physical interaction assay (RanGAP-HRE RNA binding), immunofluorescence in patient iPSC neurons and brain tissue, nuclear import assay, small molecule/ASO rescue experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal evidence from Drosophila genetic screen, physical interaction, patient-derived iPSC neurons, and patient tissue, with pharmacological rescue\",\n      \"pmids\": [\"26308891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"C9orf72 interacts with Rab1a and the ULK1 autophagy initiation complex, and as a Rab1a effector controls initiation of autophagy by regulating Rab1a-dependent trafficking of the ULK1 complex to the phagophore. Reduction of C9orf72 in cell lines and primary neurons attenuates autophagy and causes accumulation of p62-positive puncta.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, autophagy flux assays in cell lines and primary neurons, knockdown experiments, patient-derived iNeurons\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP for multiple binding partners, functional KD phenotype replicated in cell lines, primary neurons, and patient-derived iNeurons\",\n      \"pmids\": [\"27334615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"C9ORF72, together with SMCR8 and WDR41, forms a stable tripartite complex and acts as a GDP/GTP exchange factor (GEF) for the small RAB GTPases Rab8a and Rab39b, regulating macroautophagy. Decreased C9orf72 expression in neuronal cultures leads to autophagy dysfunction characterized by accumulation of p62/SQSTM1 aggregates.\",\n      \"method\": \"Co-immunoprecipitation identifying C9orf72-SMCR8-WDR41 complex, GEF activity assay for Rab8a and Rab39b, autophagy assays with p62 accumulation in neuronal cultures\",\n      \"journal\": \"Small GTPases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — GEF activity assay (enzymatic) reported but from a single lab, limited methodological detail in abstract\",\n      \"pmids\": [\"27494456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"C9orf72's long isoform complexes with and stabilizes SMCR8, which further enables interaction with WDR41, forming a tripartite complex. This complex suppresses autoimmunity and negatively regulates lysosomal exocytosis; loss of C9orf72 results in increased surface LAMP1 expression and enhanced secretion of lysosomal components in macrophages.\",\n      \"method\": \"Quantitative mass spectrometry-based proteomics in motor neurons, Smcr8 loss-of-function mutant mice, LAMP1 surface expression and lysosomal secretion assays in macrophages\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — MS-based interactome plus Smcr8 KO mouse model with defined cellular phenotypes, consistent with C9orf72 KO phenotypes\",\n      \"pmids\": [\"29950492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"C9ORF72 interacts with endosomes and is required for normal vesicle trafficking and lysosomal biogenesis in motor neurons. Repeat expansion-reduced C9orf72 expression triggers neurodegeneration via accumulation of glutamate receptors (excitotoxicity) and impaired clearance of neurotoxic dipeptide repeat proteins. Restoring C9orf72 levels or augmenting function with constitutively active RAB5 rescued patient neuron survival.\",\n      \"method\": \"Human induced motor neurons (iMNs) from patient iPSCs, endosome interaction assays, vesicle trafficking assays, lysosomal biogenesis assays, RAB5 rescue experiments\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — patient iPSC-derived iMNs with multiple orthogonal assays, pathway rescue with constitutively active RAB5, and in vivo validation in mouse models\",\n      \"pmids\": [\"29400714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"C9orf72 is a component of the ULK1-RB1CC1-ATG13-ATG101 autophagy initiation complex, interacting directly with ATG13 via the isoform-specific carboxyl-terminal DENN and dDENN domain. C9orf72 knockout neurons show reduced LC3-II puncta and reduced ULK1 levels, indicating loss of C9orf72 impairs basal autophagy. Expression of the long C9orf72 isoform (but not the short isoform) rescues autophagy and dendritic arborization phenotypes.\",\n      \"method\": \"Quantitative proteomic analysis, Co-IP (C9orf72-ATG13 interaction), c9orf72 knockout mouse neurons, LC3-II autophagy flux assay, dendritic morphology quantification, isoform rescue experiments\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — proteomic identification plus Co-IP with direct binding mapped to specific domain, KO phenotype, and isoform-specific rescue\",\n      \"pmids\": [\"30669939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"C9orf72 DENN domain specifically binds to inactive Rag GTPases (but not active Rag GTPases), thereby affecting Rag/raptor/mTOR complex function and mTORC1 activity. Loss of C9orf72 leads to accumulation of lysosomes, autophagosomes, and autolysosomes, associated with suppressed mTORC1 activity and enhanced nuclear translocation of MITF, TFE3, and TFEB.\",\n      \"method\": \"Co-immunoprecipitation (C9orf72-Rag GTPase interaction), lysosomal biogenesis assays, mTORC1 activity assays, nuclear translocation assays for MiT/TFE members, rescue with active Rag GTPases\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with specificity for inactive vs. active Rag GTPases plus multiple downstream functional assays, single lab\",\n      \"pmids\": [\"32100453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"C9orf72 and Smcr8 double-knockout mice show impaired lysosomal degradation and exocytosis due to disrupted autolysosome acidification, leading to aberrant MTOR protein accumulation and MTORC1 signaling overactivation. Inhibition of hyperactive MTORC1 partially rescued macrophage dysfunction.\",\n      \"method\": \"c9orf72 and smcr8 double-knockout (dKO) mice, lysosomal pH/acidification assays, MTORC1 signaling assays, rapamycin/pharmacological MTORC1 inhibition rescue\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO mouse model with mechanistic rescue, multiple orthogonal assays, causative link established between lysosomal degradation and MTORC1\",\n      \"pmids\": [\"31847700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss of C9orf72 from myeloid cells alone is sufficient to cause age-dependent lymphoid hypertrophy and autoinflammation. C9orf72-deficient dendritic cells show early type I interferon response hyperactivation, and C9orf72-deficient myeloid cells are selectively hyperresponsive to STING activators. Degradation of STING through the autolysosomal pathway is diminished in C9orf72-deficient myeloid cells; blocking STING suppresses the hyperactive interferon responses and inflammation.\",\n      \"method\": \"Myeloid cell-specific C9orf72 knockout mice, dendritic cell isolation with IFN response profiling, STING pathway activation assays, autolysosomal degradation assays, STING inhibitor rescue in mice and patient macrophages\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with mechanistic pathway placement (C9orf72 → STING lysosomal degradation → type I IFN), validated in mice and patient-derived cells\",\n      \"pmids\": [\"32814898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"C9orf72 deficiency in mice leads to a change in microglial homeostatic signature and transition to an inflammatory state with enhanced type I IFN response. C9orf72-depleted microglia trigger age-dependent enhanced cortical synaptic pruning, leading to altered learning and memory, and paradoxically improve amyloid plaque clearance while worsening synapse loss.\",\n      \"method\": \"C9orf72 conditional knockout in microglia, microglial transcriptomic profiling, synaptic pruning quantification, behavioral testing, amyloid mouse model crossing\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — microglial-specific KO with defined cellular mechanism (enhanced synaptic pruning) and multiple phenotypic readouts\",\n      \"pmids\": [\"34133945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"C9orf72 is a mitochondrial inner-membrane-associated protein that regulates energy homeostasis via oxidative phosphorylation. C9orf72 translocation from the cytosol to the inter-membrane space is mediated by the redox-sensitive AIFM1/CHCHD4 pathway. In mitochondria, C9orf72 specifically stabilizes TIMMDC1 (a crucial factor for OXPHOS complex I assembly) by directly recruiting the prohibitin complex to inhibit m-AAA protease-dependent degradation of TIMMDC1. Mitochondrial complex I function is impaired in C9orf72-linked ALS/FTD patient-derived neurons.\",\n      \"method\": \"Mitochondrial fractionation, Co-IP (C9orf72-TIMMDC1-prohibitin complex), m-AAA protease degradation assay, OXPHOS complex I activity assay, patient iPSC-derived neuron functional assessment\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — subcellular fractionation identifying novel mitochondrial localization, Co-IP of tripartite complex, protease degradation assay, validated in patient neurons\",\n      \"pmids\": [\"33545050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"C9orf72 interacts with synapsin family proteins at synapses via its N-terminal longin domain (interacting with the conserved C domain of synapsin). C9orf72 deficiency reduces the number of excitatory synapses, decreases synapsin levels at remaining synapses, impairs excitatory neurotransmission, and depletes synaptic vesicles from excitatory synapses. C9orf72 haploinsufficiency in patient hippocampus shows marked synapsin reduction.\",\n      \"method\": \"Co-IP of endogenous C9orf72-synapsin in synapses, domain mapping by pulldown, C9orf72 knockout mouse hippocampal analysis, electrophysiological recordings, electron microscopy of synaptic vesicles, patient postmortem tissue immunohistochemistry\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endogenous Co-IP with domain mapping, KO mouse in vivo phenotype, electrophysiology, and patient tissue validation\",\n      \"pmids\": [\"35876881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"C9orf72 localizes to the nucleus and is rapidly recruited to sites of DNA damage. C9orf72 deficiency results in impaired non-homologous end joining (NHEJ) repair through attenuated DNA-PK complex assembly and DNA damage response signaling. C9orf72 deficiency exacerbates poly-GR-induced neurodegeneration and leads to PARP-1 overactivation; PARP-1 inhibition rescued neuronal death.\",\n      \"method\": \"Immunofluorescence live imaging of nuclear C9orf72 at DNA damage sites, NHEJ repair assay, DNA-PK complex assembly assay, KO mouse model with poly-GR co-expression, PARP-1 inhibitor rescue in cultured neurons\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct nuclear localization with functional consequence, NHEJ assay, in vivo mouse model, single lab\",\n      \"pmids\": [\"36220889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"C9orf72 repeat expansion causes elevated levels of DNA-RNA hybrids (R-loops) and double-strand breaks. Defective ATM-mediated DNA repair is a consequence of P62 accumulation, which impairs H2A ubiquitylation and perturbs ATM signaling. Expression of C9orf72-related RNA and dipeptide repeats in mouse CNS increases double-strand breaks and ATM defects, triggering neurodegeneration.\",\n      \"method\": \"R-loop detection (S9.6 antibody), DSB quantification (γH2AX) in rat neurons/human cells/patient spinal cord, ATM signaling assays, P62 accumulation analysis, H2A ubiquitylation assay, viral vector mouse CNS expression model\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple model systems (rat, human cells, patient tissue, mouse) with mechanistic pathway (P62→H2A ubiquitylation→ATM), single lab\",\n      \"pmids\": [\"28714954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"C9ORF72 protein is localized as puncta throughout neurons including actin-rich structures such as filopodia and growth cones, and is present in synaptosome preparations from adult mouse brain, indicating a role at synapses. Different C9orf72 isoforms show differential nuclear vs. cytoplasmic expression over development.\",\n      \"method\": \"Cellular fractionation, immunofluorescence in cultured cortical neurons and brain tissue (developmental time-course), synaptosome preparation from adult mouse brain\",\n      \"journal\": \"Acta neuropathologica communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — fractionation and immunofluorescence establishing subcellular localization, with synaptosome biochemical fractionation, multiple developmental time points\",\n      \"pmids\": [\"26408000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Loss of C9ORF72 leads to hyperactivation of the JAK-STAT pathway and increased STING protein levels. Compromised lysosome integrity in C9ORF72-deficient cells contributes to JAK/STAT-dependent inflammatory responses. JAK inhibitor treatment rescues enhanced inflammatory phenotypes in C9ORF72-deficient cells and mice.\",\n      \"method\": \"JAK-STAT pathway activation assays in C9orf72 KO cells/mice, STING protein level measurement, lysosome integrity assays, JAK inhibitor rescue experiments in vitro and in vivo\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional KO with pathway assays and pharmacological rescue in both cell culture and mice, single lab\",\n      \"pmids\": [\"37250330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arginine-rich poly-dipeptides (PR) from C9orf72 tightly bind karyopherin-β2 (Kapβ2) at a 1:1 ratio, targeting the NLS binding site of Kapβ2. This impedes NIR (nuclear import receptor) function as a phase modifier of RNA-binding proteins, disabling phase transitions of RBPs.\",\n      \"method\": \"Isothermal titration calorimetry (ITC), size-exclusion chromatography, nuclear magnetic resonance (NMR) of Kapβ2 perturbed by PR poly-dipeptides, comparison with designed NLS peptide\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ITC (quantitative binding), SEC, and NMR with site-specific mapping of the interaction, multiple orthogonal biophysical methods in one study\",\n      \"pmids\": [\"34489423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Poly(PR) dipeptide repeat protein from C9orf72 binds DNA, localizes to heterochromatin, and causes HP1α liquid-phase disruptions, decreases in HP1α expression, abnormal histone methylation, and nuclear lamina invaginations. These lead to repetitive element expression and double-stranded RNA accumulation.\",\n      \"method\": \"(PR)50-GFP mouse model (brain-wide expression), chromatin binding assays, HP1α phase separation assays, histone methylation analysis, nuclear lamina imaging, dsRNA detection\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse model with multiple mechanistic readouts including chromatin binding, phase separation, epigenetic modification, and dsRNA accumulation\",\n      \"pmids\": [\"30765536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Poly(GR) from C9orf72 repeat expansion promotes aggregation of endogenous TDP-43 in an RNA-independent manner, causing cytoplasmic TDP-43 inclusion formation. Poly(GR) also causes mislocalization of nucleocytoplasmic transport factors and nuclear pore complex proteins, leading to aberrant TDP-43 cytoplasmic accumulation and co-aggregation with poly(GR). ASO targeting of G4C2 repeats reduced poly(GR) burden and TDP-43 pathology.\",\n      \"method\": \"Co-immunoprecipitation (poly(GR)-TDP-43), RNA-independent sequestration assay, GFP-(GR)200 mouse model with nucleocytoplasmic transport factor localization analysis, ASO treatment with biochemical and pathological readouts\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP demonstrating RNA-independent mechanism, in vivo mouse model, ASO rescue with multiple endpoints\",\n      \"pmids\": [\"32878979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The C9orf72 HRE DNA binds to DAXX protein and promotes its liquid-liquid phase separation, which reorganizes genomic structures. HRE-dependent nuclear accumulation of DAXX drives chromatin remodeling and epigenetic changes (histone hypermethylation and hypoacetylation). DAXX suppresses basal and stress-inducible expression of C9orf72 via chromatin remodeling and epigenetic modifications of the C9orf72 major transcript promoter.\",\n      \"method\": \"DNA-protein binding assay (HRE DNA-DAXX), LLPS assay, chromatin immunoprecipitation, histone modification analysis, DAXX knockdown rescue in patient-derived motor neurons\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA-protein binding, LLPS assay, ChIP-based epigenetic analysis, and functional rescue, single lab\",\n      \"pmids\": [\"36822200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"(GGGGCC)n repeat RNA co-localizes with nuclear speckles and alters their phase separation properties and granule dynamics. The nuclear speckle scaffold protein SRRM2 is sequestered into poly-GR cytoplasmic inclusions in C9-FTD/ALS mouse model and patient postmortem tissues. Impaired nuclear speckle integrity induces global exon skipping and intron retention in human iPSC-derived neurons, causing neuronal toxicity.\",\n      \"method\": \"Single molecule imaging, co-localization assays (repeat RNA-nuclear speckles), phase separation assays, SRRM2 immunohistochemistry in mouse model and patient tissue, iPSC-derived neuron RNA splicing analysis, neuronal toxicity assay\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging of RNA-nuclear speckle interaction with phase separation assay, mouse model, patient tissue, and iPSC validation, single lab\",\n      \"pmids\": [\"39181135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RAN translation of C9orf72 G4C2 repeats is regulated by double-stranded RNA-dependent protein kinase (PKR): G4C2 expansion RNAs activate PKR, leading to increased levels of multiple RAN proteins. Blocking PKR reduces RAN protein levels. p-PKR is elevated in C9orf72 ALS/FTD human and mouse brains, and inhibiting PKR (via AAV-PKR-K296R or metformin) decreases RAN proteins and improves behavior and pathology in C9orf72 BAC transgenic mice.\",\n      \"method\": \"PKR activation assays with structured repeat RNAs, PKR-K296R dominant-negative blockade, PKR-KO cells, RAN protein level quantification, C9orf72 BAC transgenic mouse AAV injection and metformin treatment with behavioral/pathological endpoints\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic PKR regulation of RAN translation established in cells, validated in human tissue, and rescued in vivo with two independent approaches\",\n      \"pmids\": [\"32690681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The RNA helicase DHX36 (G4R1) modulates C9orf72 G4C2 repeat-associated non-AUG (RAN) translation: DHX36 depletion suppresses RAN translation in a repeat length-dependent manner, while DHX36 overexpression enhances RAN translation from G4C2 reporter RNAs. DHX36 is required for integrated stress response-triggered upregulation of RAN translation.\",\n      \"method\": \"Luciferase reporter assays in cells and in vitro, DHX36 depletion and overexpression experiments, integrated stress response activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays both in cells and in vitro with gain- and loss-of-function, single lab\",\n      \"pmids\": [\"34174288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Neurons expressing poly(PR) from the C9orf72 repeat expansion activate a highly specific p53-dependent transcriptional program. Ablating p53 in mice completely rescues neurons from poly(PR)-induced degeneration and markedly increases survival in a C9orf72 mouse model. p53 activates downstream Puma to drive neurodegeneration.\",\n      \"method\": \"Chromatin accessibility profiling (ATAC-seq) and transcriptomics in degenerating neurons, p53 knockout in C9orf72 mouse model, axonal degeneration assay, patient iPSC motor neuron survival assay, C9orf72 fly model\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multi-omic approach identifying p53 as central node, KO rescue in vivo, validated across mouse, iPSC, and fly models\",\n      \"pmids\": [\"33482083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Spliced circular intron (not pre-mRNA) containing G4C2 repeats serves as the translation template for dipeptide repeat proteins in C9ORF72 ALS/FTD. The spliced intron is stabilized in circular form due to defective lariat debranching. The NXF1-NXT1 pathway plays an important role in nuclear export of this circular intron and modulates toxic DPR production.\",\n      \"method\": \"Single molecule imaging of repeat RNA species, circular RNA characterization (lariat debranching assay), NXF1-NXT1 pathway perturbation, DPR production assays with reporter system\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single molecule imaging combined with mechanistic identification of circular intron as translation template and NXF1-NXT1 pathway role, single lab\",\n      \"pmids\": [\"34389711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"C9orf72 deficiency in macrophages results in impaired lysosomal degradation and exocytosis. C9orf72 loss of function alone (in rat) does not cause ALS phenotypes, but C9orf72 ablation combined with kainic acid-induced excitotoxicity produces motor deficits, motor neuron loss, Golgi complex fragmentation, and abnormal vesicle trafficking.\",\n      \"method\": \"C9orf72 gene deletion in rats, kainic acid excitotoxicity model, motor function testing, motor neuron histology, vesicle trafficking assays, RNA sequencing\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO rat model with direct excitotoxic challenge establishing synergistic mechanism, defined cellular phenotypes\",\n      \"pmids\": [\"32745320\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"C9ORF72 encodes a DENN-domain protein that forms a tripartite complex with SMCR8 and WDR41, functioning as a GEF for Rab GTPases (including Rab8a and Rab39b) to regulate vesicle trafficking, lysosomal homeostasis, mTORC1 signaling, and autophagy initiation (via direct interaction with ATG13 and the ULK1 complex); it also localizes to mitochondria to stabilize complex I assembly (by protecting TIMMDC1 from m-AAA protease degradation via the prohibitin complex), to the nucleus where it facilitates NHEJ DNA repair and is recruited to DNA damage sites, and to synapses where it interacts with synapsin to regulate excitatory neurotransmission; loss of C9ORF72 in myeloid cells impairs autolysosomal degradation of STING, causing JAK-STAT and type I interferon hyperactivation and autoinflammation, while the pathogenic GGGGCC repeat expansion simultaneously reduces C9ORF72 protein levels (haploinsufficiency) and generates toxic RNA foci that sequester RBPs and disrupt nucleocytoplasmic transport via RanGAP1 mislocalization, as well as dipeptide repeat proteins (particularly arginine-rich PR/GR) that disrupt nuclear import receptors, heterochromatin integrity, nuclear speckle function, and promote TDP-43 aggregation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"C9ORF72 is a DENN-domain protein that organizes membrane trafficking, lysosomal homeostasis, and autophagy, and its disruption by a noncoding GGGGCC hexanucleotide repeat expansion causes ALS/FTD through combined loss-of-function and RNA/protein gain-of-function mechanisms [#0, #1]. The long C9ORF72 isoform forms a stable tripartite complex with SMCR8 and WDR41 that acts as a guanine-nucleotide exchange factor for Rab GTPases including Rab8a and Rab39b, and engages Rab1a and the ULK1–RB1CC1–ATG13–ATG101 initiation complex—binding ATG13 directly through its isoform-specific C-terminal DENN/dDENN domain—to drive autophagy and lysosomal biogenesis [#3, #4, #7]. Through its DENN domain it also binds inactive Rag GTPases to tune mTORC1 signaling and MiT/TFE-dependent lysosomal gene programs, and loss of C9ORF72/SMCR8 impairs autolysosome acidification and degradation while enhancing lysosomal exocytosis [#8, #9, #5]. Beyond the lysosome, C9ORF72 localizes to the mitochondrial inner membrane where it recruits the prohibitin complex to protect TIMMDC1 from m-AAA protease degradation and sustain complex I assembly [#12], to the nucleus where it is recruited to DNA damage sites to promote DNA-PK assembly and NHEJ repair [#14], and to synapses where its N-terminal longin domain binds synapsin to support excitatory neurotransmission and synaptic vesicle pools [#13]. In myeloid cells C9ORF72 loss impairs autolysosomal degradation of STING, driving type I interferon and JAK-STAT hyperactivation and autoinflammation [#10, #17], and alters microglial homeostasis and synaptic pruning [#11]. The repeat expansion reduces C9ORF72 levels (haploinsufficiency) and generates toxic RNA foci that mislocalize RanGAP1 and disrupt nucleocytoplasmic transport [#2], while repeat-associated non-AUG translation—templated by a spliced circular intron and regulated by PKR and DHX36—produces dipeptide repeat proteins; arginine-rich PR/GR species bind karyopherin-β2, disrupt HP1α-dependent heterochromatin, sequester the nuclear speckle scaffold SRRM2, and promote TDP-43 aggregation [#18, #19, #20, #22, #23, #24, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the genetic cause of C9-ALS/FTD and framed the dual disease logic, showing the GGGGCC expansion both lowers a C9ORF72 transcript (loss-of-function) and forms nuclear RNA foci (RNA gain-of-function).\",\n      \"evidence\": \"Genetic linkage, repeat expansion identification, transcript analysis, and RNA foci detection in patient tissue\",\n      \"pmids\": [\"21944778\", \"21944779\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the normal protein function lost\", \"Did not establish which mechanism dominates pathogenesis\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided the first hypothesis for C9ORF72 molecular function by recognizing it as a DENN-domain Rab-GEF-like protein, predicting a role in membrane trafficking.\",\n      \"evidence\": \"Sensitive computational homology searches\",\n      \"pmids\": [\"23329412\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational prediction only with no functional validation in this study\", \"No Rab substrate identified\", \"No subcellular localization tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated an RNA gain-of-function pathway, showing repeat RNA binds and mislocalizes RanGAP1 to impair nucleocytoplasmic transport, and that this is pharmacologically reversible.\",\n      \"evidence\": \"Drosophila genetic screen, RanGAP–HRE RNA binding, patient iPSC neuron and brain immunofluorescence, nuclear import assays, small molecule/ASO rescue\",\n      \"pmids\": [\"26308891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of foci vs DPRs to transport defect not resolved\", \"Does not address protein loss-of-function arm\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Localized endogenous C9ORF72 to neuronal puncta, actin-rich growth structures, and synaptosomes, providing early evidence for a synaptic and developmentally regulated role.\",\n      \"evidence\": \"Cellular fractionation, immunofluorescence time-course, and synaptosome preparation from mouse brain\",\n      \"pmids\": [\"26408000\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No molecular partner at synapses identified here\", \"Isoform-specific localization not mechanistically explained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Converted the GEF prediction into function, defining the C9ORF72–SMCR8–WDR41 complex as a Rab8a/Rab39b GEF and as a Rab1a effector controlling ULK1-complex trafficking and autophagy initiation.\",\n      \"evidence\": \"Co-IP, pulldowns, in vitro GEF assays, and autophagy flux/p62 assays in cell lines, primary neurons, and patient iNeurons\",\n      \"pmids\": [\"27334615\", \"27494456\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF activity characterized in single labs\", \"Quantitative kinetics of nucleotide exchange not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed C9ORF72 in vesicle trafficking and lysosomal biogenesis in motor neurons and linked its reduction to glutamate receptor accumulation and excitotoxic neurodegeneration rescuable by active RAB5.\",\n      \"evidence\": \"Patient iPSC-derived iMNs with endosome, trafficking, and lysosomal assays plus constitutively active RAB5 rescue and mouse validation\",\n      \"pmids\": [\"29400714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Rab5 GEF relationship not biochemically defined here\", \"Link between trafficking defect and receptor accumulation correlative\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined complex architecture and an immune-suppressive role, showing C9ORF72 stabilizes SMCR8 to assemble the tripartite complex and that the complex restrains lysosomal exocytosis and autoimmunity.\",\n      \"evidence\": \"Quantitative MS interactomics, Smcr8 mutant mice, and LAMP1 surface/secretion assays in macrophages\",\n      \"pmids\": [\"29950492\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular control of exocytosis not fully defined\", \"Connection to specific Rab effectors of exocytosis unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapped a direct, isoform-specific autophagy mechanism, placing C9ORF72 as an ATG13-binding component of the ULK1 initiation complex via its C-terminal DENN/dDENN domain.\",\n      \"evidence\": \"Quantitative proteomics, Co-IP with domain mapping, c9orf72 KO mouse neurons, LC3-II flux, and isoform-specific rescue of autophagy and dendritic phenotypes\",\n      \"pmids\": [\"30669939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Short isoform function remains undefined\", \"How ATG13 binding integrates with Rab-GEF activity unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected C9ORF72 to nutrient signaling by showing its DENN domain selectively binds inactive Rag GTPases to modulate mTORC1 and MiT/TFE lysosomal transcription.\",\n      \"evidence\": \"Co-IP with active/inactive Rag specificity, mTORC1 and MiT/TFE nuclear translocation assays, and active-Rag rescue\",\n      \"pmids\": [\"32100453\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP without structural validation\", \"Whether C9ORF72 acts as a GEF/GDF for Rags not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked the expansion to genome instability, showing R-loop and double-strand break accumulation downstream of p62-mediated impairment of H2A ubiquitylation and ATM signaling.\",\n      \"evidence\": \"R-loop (S9.6) and γH2AX detection across rat neurons, human cells, and patient spinal cord, ATM and H2A ubiquitylation assays, and viral CNS expression model\",\n      \"pmids\": [\"28714954\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab mechanism\", \"Separation of RNA vs DPR contribution to DSBs incomplete\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a chromatin gain-of-function for arginine-rich DPRs, showing poly(PR) binds heterochromatin and disrupts HP1α phase behavior, histone methylation, and nuclear lamina, derepressing repetitive elements.\",\n      \"evidence\": \"(PR)50-GFP mouse model with chromatin binding, phase separation, epigenetic, and dsRNA readouts\",\n      \"pmids\": [\"30765536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Disease relevance of supraphysiologic PR expression\", \"Link to downstream neuronal death not fully traced\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a causal lysosome-to-mTORC1 axis in immune cells, showing C9orf72/Smcr8 loss disrupts autolysosome acidification and overactivates MTORC1, rescuable by mTORC1 inhibition.\",\n      \"evidence\": \"c9orf72/smcr8 double-KO mice with lysosomal pH, MTORC1 signaling assays, and rapamycin rescue\",\n      \"pmids\": [\"31847700\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Apparent opposing mTORC1 effects across studies not reconciled\", \"Cell-type specificity of mTORC1 regulation unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a myeloid autoinflammation mechanism, showing C9ORF72 loss impairs autolysosomal STING degradation to drive type I interferon hyperactivation and inflammation reversible by STING blockade.\",\n      \"evidence\": \"Myeloid-specific C9orf72 KO mice, IFN profiling, STING activation and autolysosomal degradation assays, and STING-inhibitor rescue in mice and patient macrophages\",\n      \"pmids\": [\"32814898\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of STING delivery to autolysosomes not detailed\", \"Relevance to neuronal pathology indirect\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended the immune phenotype to brain, showing C9orf72-deficient microglia shift to an inflammatory state with enhanced synaptic pruning that impairs cognition while paradoxically clearing amyloid.\",\n      \"evidence\": \"Microglia-specific KO with transcriptomics, synaptic pruning quantification, behavior, and amyloid model crossing\",\n      \"pmids\": [\"34133945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular driver of enhanced pruning not pinpointed\", \"Link to type I IFN signature causal chain incomplete\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed C9ORF72 loss-of-function is insufficient alone for ALS phenotypes in rat but synergizes with excitotoxicity, supporting a multi-hit pathogenic model.\",\n      \"evidence\": \"C9orf72 KO rat combined with kainic acid excitotoxicity, motor and histological assays, and RNA-seq\",\n      \"pmids\": [\"32745320\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Species/strain dependence of phenotype\", \"Molecular basis of excitotoxic synergy undefined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined an RNA-independent DPR toxicity route, showing poly(GR) directly drives TDP-43 aggregation and nuclear transport disruption, with ASO rescue tying it back to the repeat.\",\n      \"evidence\": \"poly(GR)-TDP-43 Co-IP, RNA-independent sequestration assays, GR mouse model, and ASO treatment\",\n      \"pmids\": [\"32878979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GR initiates or amplifies TDP-43 pathology unresolved\", \"Quantitative contribution relative to RNA foci unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a mitochondrial function for C9ORF72, showing inner-membrane localization where it recruits prohibitin to protect TIMMDC1 from m-AAA protease degradation and sustain complex I.\",\n      \"evidence\": \"Mitochondrial fractionation, Co-IP of C9orf72–TIMMDC1–prohibitin, protease degradation and complex I activity assays, and patient neuron assessment\",\n      \"pmids\": [\"33545050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship of mitochondrial pool to the SMCR8/WDR41 complex unknown\", \"Trigger for cytosol-to-mitochondria translocation in disease unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided biophysical detail for PR-mediated transport disruption, showing poly(PR) binds karyopherin-β2 at its NLS site 1:1 to impair nuclear import receptor phase-modifier function.\",\n      \"evidence\": \"ITC, size-exclusion chromatography, and NMR mapping of Kapβ2–PR interaction\",\n      \"pmids\": [\"34489423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequence of this specific interaction not quantified here\", \"Selectivity across import receptors not fully mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified the regulatory machinery of RAN translation, showing PKR activation by structured repeat RNA and DHX36 helicase activity control DPR production, with PKR inhibition therapeutic in mice.\",\n      \"evidence\": \"PKR activation/dominant-negative and KO assays, DHX36 gain/loss reporter assays, and AAV-PKR-K296R/metformin rescue in BAC transgenic mice\",\n      \"pmids\": [\"32690681\", \"34174288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DHX36 findings from single-lab reporter assays\", \"Integration of PKR and DHX36 in same pathway not fully tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Pinpointed the DPR translation template and its export route, showing a spliced circular intron stabilized by defective lariat debranching is exported by NXF1-NXT1 to template DPR synthesis.\",\n      \"evidence\": \"Single molecule imaging, circular RNA/lariat debranching characterization, and NXF1-NXT1 perturbation with DPR reporters\",\n      \"pmids\": [\"34389711\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab characterization\", \"Relative DPR contribution from circular intron vs pre-mRNA unquantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified p53 as a central effector node, showing poly(PR) activates a p53–Puma program whose ablation rescues neurodegeneration across multiple models.\",\n      \"evidence\": \"ATAC-seq/transcriptomics, p53 KO rescue in C9orf72 mice, axonal degeneration, iPSC motor neuron survival, and fly model\",\n      \"pmids\": [\"33482083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal linking PR to p53 activation undefined\", \"Whether p53 axis operates downstream of loss-of-function unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established a direct synaptic mechanism, mapping C9ORF72's N-terminal longin domain to synapsin and showing its loss reduces excitatory synapses, neurotransmission, and synaptic vesicle pools.\",\n      \"evidence\": \"Endogenous Co-IP with domain mapping, KO mouse hippocampal electrophysiology and EM, and patient tissue immunohistochemistry\",\n      \"pmids\": [\"35876881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of synapsin binding on vesicle cycling not fully resolved\", \"Relation to trafficking/autophagy roles unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a nuclear DNA-repair function, showing C9ORF72 is recruited to damage sites and promotes DNA-PK assembly and NHEJ, with its loss exacerbating poly-GR toxicity via PARP-1 overactivation.\",\n      \"evidence\": \"Live imaging of nuclear recruitment, NHEJ and DNA-PK assembly assays, KO mouse with poly-GR co-expression, and PARP-1 inhibitor rescue\",\n      \"pmids\": [\"36220889\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab mechanism\", \"How a trafficking protein engages NHEJ machinery structurally undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended inflammatory signaling, showing C9ORF72 loss elevates STING and hyperactivates JAK-STAT through compromised lysosome integrity, rescuable by JAK inhibition.\",\n      \"evidence\": \"JAK-STAT and STING assays in KO cells/mice, lysosome integrity assays, and JAK-inhibitor rescue in vitro and in vivo\",\n      \"pmids\": [\"37250330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Overlap with prior STING/IFN mechanism not fully integrated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linked the repeat to its own transcriptional silencing, showing HRE DNA binds DAXX and promotes its phase separation, driving chromatin remodeling that suppresses C9orf72 expression.\",\n      \"evidence\": \"HRE DNA–DAXX binding, LLPS assays, ChIP/histone modification analysis, and DAXX knockdown rescue in patient motor neurons\",\n      \"pmids\": [\"36822200\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Contribution of DAXX-driven silencing to overall haploinsufficiency unquantified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified nuclear speckle dysfunction as a toxicity mechanism, showing repeat RNA alters speckle phase properties and poly-GR sequesters SRRM2, causing splicing defects and neurotoxicity.\",\n      \"evidence\": \"Single molecule imaging, phase separation assays, SRRM2 immunohistochemistry in mouse and patient tissue, and iPSC neuron splicing/toxicity analysis\",\n      \"pmids\": [\"39181135\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Causal ranking among speckle, transport, and TDP-43 mechanisms unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the distinct subcellular activities of C9ORF72 (lysosomal GEF, mitochondrial complex I support, nuclear NHEJ, synaptic synapsin binding) are coordinated, and how loss-of-function and the multiple gain-of-function arms are quantitatively weighted in driving neurodegeneration.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the C9ORF72-SMCR8-WDR41 complex with Rab substrates reported in the corpus\", \"Integration of immune, neuronal, and metabolic phenotypes into one pathogenic sequence lacking\", \"Relative therapeutic value of targeting loss vs RNA vs DPR mechanisms unestablished\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 8]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 7, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [5, 6, 8, 9]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [14, 16]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [3, 4, 7]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 17]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [14, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [\n      \"C9ORF72-SMCR8-WDR41 complex\",\n      \"ULK1-RB1CC1-ATG13-ATG101 autophagy initiation complex\"\n    ],\n    \"partners\": [\n      \"SMCR8\",\n      \"WDR41\",\n      \"ATG13\",\n      \"Rab1a\",\n      \"Rab8a\",\n      \"TIMMDC1\",\n      \"synapsin\",\n      \"RanGAP1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}